Aurobac Therapeutics
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
29 Avenue Tony Garnier, Lyon, Auvergne-R...Website
www.aurobac-tx.comRevenue
<$5 MillionIndustry
About Aurobac Therapeutics
Aurobac Therapeutics Org Chart
Is Aurobac Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aurobac Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aurobac Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aurobac Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Aurobac Therapeutics has new funding data
Product Launch: Get notified when Aurobac Therapeutics launches new products
Check if Aurobac Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aurobac Therapeutics recently announced quarterly report
Check out if Aurobac Therapeutics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aurobac Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aurobac Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aurobac Therapeutics.
Aurobac Therapeutics Tech Stack
A closer look at the technologies used by Aurobac Therapeutics
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aurobac Therapeutics
AUROBAC THERAPEUTICS is a biopharmaceutical company focused on developing precision medicines to combat severe bacterial infections, particularly in acute hospital settings. Founded in 2022, the company addresses critical medical needs related to antimicrobial resistance, acute respiratory infections, and sepsis. Their research and development stra... Read More